WHO ICTRP trial
A randomized phase IIa study: natural dendritic cells for immunotherapy of…
NL-OMON42196 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON42196 |
|---|---|
| Public title | A randomized phase IIa study: natural dendritic cells for immunotherapy of chemo-naive metastatic castration-resistant prostate cancer patients |
| Scientific title | A randomized phase IIa study: natural dendritic cells for immunotherapy of chemo-naive metastatic castration-resistant prostate cancer patients - Natural DC for mCRPC |
| Primary sponsor | Tumor Immunologie |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | The Netherlands |
| Conditions | mCRPC metastatic hormone-insensitive prostate cancer;10038364;mCRPC;metastatic hormone-insensitive prostate cancer |
| Interventions | Leukapheresis Venapunction Intranodal administration of the natural DC Delayed-type hypertensitivity test and biopsies of the challanged skin ;Immunotherapy;metastatic castration-resistant prostate cancer;natural dendritic cell vaccination |
| Registration date | Jan 13, 2016 |
| Target size | 21 |
| Secondary IDs | 2012-002531-29;NL49143.000.14 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: